Morocco approves Chinese Sinopharm COVID-19 vaccine

  • World
  • Saturday, 23 Jan 2021

RABAT, Jan. 22 (Xinhua) -- Morocco on Friday approved the emergency use of Chinese Sinopharm COVID-19 vaccine, the Health Ministry said in a statement.

"The vaccine meets all the conditions of quality, efficacy and safety, and does not present any potential side effects," it said.

The first batch of coronavirus vaccines developed by Sinopharm will arrive in Morocco on Jan. 27, the ministry said earlier.

The North African country has secured acquisition of 66 million doses of COVID-19 vaccine from China's Sinopharm and Britain's Oxford University and AstraZeneca.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 1
Cxense type: free
User access status: 3
Subscribe now to our Premium Plan for an ad-free and unlimited reading experience!

Next In World

Italy's election result is cause for concern, Dutch PM says
New cypher for Britain's King Charles unveiled
U.S.-listed Chinese firms trade mostly higher
Ukraine annexation votes to end amid Russian mobilisation exodus
U.S. agricultural futures fall
U.S. dollar jumps as sterling dips
Int'l tourism recovers, but nowhere near pre-pandemic levels: UN agency
Brazil's FDI hits highest level in 10 years
DUH suggests Germany to drop Christmas lights tradition during energy crisis
U.S. stocks close lower

Others Also Read